CBIZ (NYSE:CBZ – Get Free Report) posted its quarterly earnings data on Thursday. The business services provider reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.29), Briefing.com reports. CBIZ had a return on equity of 14.88% and a net margin of 7.12%. The business had revenue of $420.00 million for the quarter, compared to analysts’ expectations of $430.38 million. During the same quarter in the prior year, the firm earned $0.55 earnings per share. CBIZ’s revenue for the quarter was up 5.4% compared to the same quarter last year.
CBIZ Stock Performance
NYSE:CBZ traded down $2.00 during midday trading on Friday, reaching $71.05. 789,115 shares of the company traded hands, compared to its average volume of 399,357. CBIZ has a twelve month low of $49.15 and a twelve month high of $86.36. The firm has a market capitalization of $3.56 billion, a price-to-earnings ratio of 28.77 and a beta of 0.93. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.54 and a quick ratio of 1.54. The company has a fifty day moving average price of $77.02 and a 200 day moving average price of $74.52.
Analysts Set New Price Targets
Separately, StockNews.com downgraded CBIZ from a “hold” rating to a “sell” rating in a report on Tuesday, July 16th.
About CBIZ
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Read More
- Five stocks we like better than CBIZ
- What is a Low P/E Ratio and What Does it Tell Investors?
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- Roth IRA Calculator: Calculate Your Potential Returns
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.